Brendan J. Brodeur
Entwistle & Cappucci LLP
- Address of record
- 230 Park Ave, Floor 3, New York, NY 10169, 212-894-7200
- Phone
- (212) 894-7200
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
- Settlement fund
- $17M
- Claim deadline
- August 28, 2026
- Represents
- The Arbitrage Fund, AltShares Merger Arbitrage ETF, AltShares Event-Driven ETF, iMGP Alternative Strategies Fund, Chicago Capital Management, LP
Alta Mesa Resources Securities Litigation Settlement
Class plaintiffs alleged securities law violations against Alta Mesa Resources and related defendants concerning the company's merger and business combination. The defendants have agreed to settle all claims for $126.3 million in cash, with the Court entering final judgment approving the settlement on May 6, 2025.
- Settlement fund
- $126.3M
- Claim deadline
- Represents
- FNY Partners Fund LP, FNY Managed Accounts, LLC, Paul J. Burbach, Jr.
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.